Allevion to Present at the Biotech Showcase™ Annual Conference on January 9, 2018
Presentation To Highlight Free Market For Surgery
Miami, Dec 30, 2017
Allevion has announced today that it will present at Biotech Showcase ™ 2018, to be held January 8–10 during the most important week in healthcare at the Hilton San Francisco Union Square. Arnon Krongrad, M.D., CEO, will present at the Biotech Showcase™ as follows:
Date: Tuesday, January 9, 2018
Time: 8:30 A.M. PST
Room: Franciscan D
Venue: Hilton San Francisco Union Square Hotel, 333 O’Farrell Street, San Francisco, CA (United States)
Allevion makes and markets surgery packages. Its Surgeo® online marketplace enables customers to take control of their surgery shopping and sort choices by surgeon, price, and location. Allevion's technology enables device makers and facilities to embed their offerings in surgery packages and seize consumer friendly, alternative routes to market.
Biotech Showcase™, produced by Demy-Colton and EBD Group, is an investor and networking conference devoted to providing private and public biotechnology and life sciences companies with an opportunity to present to, and meet with, investors and pharmaceutical executives in one place during the course of one of the industry's largest annual healthcare investor conferences, J.P. Morgan Annual Healthcare Conference. Sara Demy-Colton, CEO of Demy-Colton, said: “We are delighted that Allevion will be presenting at Biotech Showcase this year. Biotech Showcase is the perfect platform for life science companies to showcase their innovation and seek out their next deal. This year again we are thrilled to be hosting what we believe will be the great business development opportunity of 2018.”
Allevion makes and markets surgery packages. Its Surgeo® online marketplace enables customers to take control of their surgery shopping and sort choices by surgeon, price, and location. Allevion's technology enables device makers and facilities to embed their offerings in surgery packages and seize consumer friendly, alternative routes to market. Said Dr. Krongrad: "Surgical patients are online and they want service. Our free market approach, which works for uninsured and insured patients, satisfies their desires while enabling our device and facility partners to seize differentiating, consumer friendly, alternate routes to market. We're excited to be joining Biotech Showcase in San Francisco and looking forward to more broadly driving value in the market."
Contact Dr. Krongrad at [email protected]
For more information, follow:
Dr. Krongrad at https://twitter.com/ArnonKrongrad
Surgeo, an Allevion public free market, at https://twitter.com/Surgeo
Biotech Showcase at https://twitter.com/EBDGroup and https://twitter.com/Demy_Colton - #BiotechShowcase #BTS18